FDA warns heart patients about antibiotic clarithromycin

February 23, 2018

(HealthDay)—The antibiotic clarithromycin (brand name: Biaxin) may increase the long-term risk of heart problems and death in patients with heart disease, according to U.S. health officials.

As a result, the federal Food and Drug Administration said Thursday that it's recommending that doctors carefully weigh the benefits and risks of the drug before prescribing it to patients with .

The agency said its warning is based on a 10-year follow-up study of patients with . The study found an unexpected and unexplained increase in deaths among heart disease patients who took clarithromycin for two weeks and were followed for one year or longer.

There's no clear explanation for how clarithromycin would increase heart disease patients' risk of death, the FDA said in a news release.

One heart specialist said this type of alert is worth heeding, however.

"It is important for health professionals and pharmacists to identify potential interactions between medications and eliminate prescription errors to prevent this risk," said Dr. Marcin Kowalski. He directs cardiac electrophysiology at Staten Island University Hospital in New York City.

The FDA said it has added a new warning about this increased risk for , and is advising doctors to consider prescribing other antibiotics to these patients. The agency added that it will continue to monitor safety reports in patients taking clarithromycin.

The antibiotic is used to treat many types of infections affecting the skin, ears, sinuses, lungs and other parts of the body.

Doctors should talk to their heart patients about the risks and benefits of clarithromycin and alternative treatments. If doctors prescribe clarithromycin to patients with heart disease, they should inform those patients about the signs and symptoms of cardiovascular problems, the FDA said.

And patients with heart disease should tell their doctor about their condition, especially when they are being prescribed an antibiotic to treat an infection.

Heart disease should not stop taking their heart disease medicine or antibiotic without first talking to their doctor, the FDA said.

Patients taking the antibiotic should seek immediate medical attention if they experience symptoms of a heart attack or stroke, such as chest pain, shortness of breath or trouble breathing, pain or weakness in one part or side of the body, or slurred speech, the agency said.

Dr. Satjit Bhusri is a cardiologist at Lenox Hill Hospital in New York City.

He said, "Although this study suggests an association between this specific antibiotic, there have not been any direct correlations to increased disease.

"I would also extend this to all in general. A short course of antibiotic therapy for a bacterial infection should be initiated if indicated by the physician; and a history of , at this time, should not be considered a risk factor for ," he said.

Explore further: Common antibiotic linked to heart problems in patients with lung conditions

More information: The U.S. National Library of Medicine has more on clarithromycin.

Related Stories

Common antibiotic linked to heart problems in patients with lung conditions

March 21, 2013
The antibiotic clarithromycin – widely used for treating lower respiratory tract infections like pneumonia and acute exacerbations (sudden worsening) of chronic obstructive pulmonary disease (COPD) – may be associated ...

FDA adds heart risk warning to popular antibiotic Zithromax

March 12, 2013
The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.

Common antibiotic linked with heart deaths

August 19, 2014
The antibiotic clarithromycin—widely used for treating common bacterial infections—is associated with an increased risk of heart deaths, finds a study published in the BMJ today.

Higher risk of dying due to heart cell damage without any symptoms occurs during or after non-heart surgery

December 4, 2017
Surgery that doesn't involve the heart may cause damage to the heart in people with known or at high risk of developing heart disease and was associated with an increased risk of death, according to new research in the American ...

Statins plus certain antibiotics may set off toxic reaction, study says

June 17, 2013
(HealthDay)—Doctors should avoid ordering certain antibiotics for older patients who take cholesterol-lowering statin drugs, such as Lipitor, Canadian researchers say.

Is low-dose aspirin right for you after surgery?

November 14, 2017
(HealthDay)—Each year, millions of American heart patients go "under the knife" for various kinds of surgery. Often they're told to take a low-dose aspirin, to help lower their odds for a post-op blood clot.

Recommended for you

Majority of U.S. adults have poor heart health: study

March 19, 2018
(HealthDay)—America's heart health went from bad to worse between 1988 and 2014, a new report warns.

Drinking alcohol makes your heart race

March 18, 2018
The more alcohol you drink, the higher your heart rate gets, according to research presented today at EHRA 2018 Congress, organized by the European Society of Cardiology.

Study of nearly 300,000 people challenges the 'obesity paradox'

March 15, 2018
The idea that it might be possible to be overweight or obese but not at increased risk of heart disease, otherwise known as the "obesity paradox", has been challenged by a study of nearly 300,000 people published in in the ...

Mending broken hearts with cardiomyocyte molds

March 13, 2018
2.5 billion. That's approximately the number of times the human heart beats in 70 years. And sometimes during the course of its unrelenting contractions and relaxations, the heart muscle can no longer bear the strain.

Common infections a bigger heart disease and stroke risk than obesity

March 13, 2018
A major study into the impact of common infections leading to hospitalisation has found they may substantially increase the risk of heart attacks, strokes and in the longer term, death.

Aspirin prevents venous thromboembolism following major orthopedic surgeries, study finds

March 13, 2018
A multicentre, double-blind, randomized, controlled clinical trial of patients who underwent total hip or knee replacement surgery showed that aspirin was as effective as rivaroxaban, the standard anti-coagulation medication, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.